PE-conjugated Anti-CD22 (pinatuzumab biosimilar) mAb, IgG1, Human Humanized
Artikelnummer:
ABI-12-9089-PE
| Artikelname: |
PE-conjugated Anti-CD22 (pinatuzumab biosimilar) mAb, IgG1, Human Humanized |
| Artikelnummer: |
ABI-12-9089-PE |
| Hersteller Artikelnummer: |
12-9089-PE |
| Alternativnummer: |
ABI-12-9089-PE-100TESTS |
| Hersteller: |
Abeomics |
| Wirt: |
Human Humanized |
| Kategorie: |
Antikörper |
| Applikation: |
FC |
| Spezies Reaktivität: |
Human |
| Konjugation: |
PE |
| Alternative Synonym: |
CD22,SIGLEC2,BL-CAM,SIGLEC-2,Siglec2,SIGLEC2FLJ22814,ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000 |
| Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Isotyp: |
IgG1 |
| UniProt: |
P20273 |
| Puffer: |
Liquid PBS with 0.05% Proclin300, 1% BSA |
| Target-Kategorie: |
CD22 |
| Application Verdünnung: |
Flow Cyt 1:100 |
